170 related articles for article (PubMed ID: 29674968)
1. Peripherally Administered Y
Ailanen L; Vähätalo LH; Salomäki-Myftari H; Mäkelä S; Orpana W; Ruohonen ST; Savontaus E
Front Pharmacol; 2018; 9():319. PubMed ID: 29674968
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.
Ailanen L; Ruohonen ST; Vähätalo LH; Tuomainen K; Eerola K; Salomäki-Myftari H; Röyttä M; Laiho A; Ahotupa M; Gylling H; Savontaus E
J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933
[TBL] [Abstract][Full Text] [Related]
3. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
[TBL] [Abstract][Full Text] [Related]
4. Effect of Blocking of Neuropeptide Y Y2 Receptor on Tumor Angiogenesis and Progression in Normal and Diet-Induced Obese C57BL/6 Mice.
Alasvand M; Rashidi B; Javanmard SH; Akhavan MM; Khazaei M
Glob J Health Sci; 2015 Mar; 7(7 Spec No):69-78. PubMed ID: 26153206
[TBL] [Abstract][Full Text] [Related]
5. Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons.
Vähätalo LH; Ruohonen ST; Mäkelä S; Ailanen L; Penttinen AM; Stormi T; Kauko T; Piscitelli F; Silvestri C; Savontaus E; Di Marzo V
Nutr Diabetes; 2015 Apr; 5(4):e151. PubMed ID: 25915740
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.
Hökfelt T; Broberger C; Zhang X; Diez M; Kopp J; Xu Z; Landry M; Bao L; Schalling M; Koistinaho J; DeArmond SJ; Prusiner S; Gong J; Walsh JH
Brain Res Brain Res Rev; 1998 May; 26(2-3):154-66. PubMed ID: 9651513
[TBL] [Abstract][Full Text] [Related]
7. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity.
Shi YC; Lin S; Castillo L; Aljanova A; Enriquez RF; Nguyen AD; Baldock PA; Zhang L; Bijker MS; Macia L; Yulyaningsih E; Zhang H; Lau J; Sainsbury A; Herzog H
Obesity (Silver Spring); 2011 Nov; 19(11):2137-48. PubMed ID: 21546930
[TBL] [Abstract][Full Text] [Related]
8. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
[TBL] [Abstract][Full Text] [Related]
10. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
11. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome.
Kuo LE; Czarnecka M; Kitlinska JB; Tilan JU; Kvetnanský R; Zukowska Z
Ann N Y Acad Sci; 2008 Dec; 1148():232-7. PubMed ID: 19120115
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
13. Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons.
Ruohonen ST; Vähätalo LH; Savontaus E
Int J Pept; 2012; 2012():452524. PubMed ID: 23118773
[TBL] [Abstract][Full Text] [Related]
14. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
15. Y2 receptor signalling in NPY neurons controls bone formation and fasting induced feeding but not spontaneous feeding.
Qi Y; Fu M; Herzog H
Neuropeptides; 2016 Feb; 55():91-7. PubMed ID: 26444586
[TBL] [Abstract][Full Text] [Related]
16. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
18. Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice.
Huang XF; Yu Y; Li Y; Tim S; Deng C; Wang Q
Neurochem Res; 2008 Sep; 33(9):1881-8. PubMed ID: 18357520
[TBL] [Abstract][Full Text] [Related]
19. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice.
Rahardjo GL; Huang XF; Tan YY; Deng C
Endocrinology; 2007 Oct; 148(10):4704-10. PubMed ID: 17615145
[TBL] [Abstract][Full Text] [Related]
20. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
